Acute effects of intravenous administration of pamidronate in patients with osteoporosis. [electronic resource]
- Journal of Korean medical science Sep 2010
- 1277-83 p. digital
Publication Type: Journal Article
1598-6357
10.3346/jkms.2010.25.9.1277 doi
Acute-Phase Proteins--biosynthesis Adult Aged Aged, 80 and over Alendronate--pharmacology Biomarkers--blood Blood Cells--drug effects Bone Density Conservation Agents--administration & dosage C-Reactive Protein--genetics Calcium--blood Collagen Type I--blood Diphosphonates--administration & dosage Female Humans Injections, Intravenous Interferon-gamma--blood Interleukin-6--blood Male Middle Aged Osteoporosis--drug therapy Pamidronate Peptides--blood RNA, Messenger--metabolism Tumor Necrosis Factor-alpha--genetics